3.6620
-0.0540
(-1.45%)
At close: January 31 at 5:25:12 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
124,808.0000
-267,887.0000
-286,177.0000
-733,128.0000
522,403.0000
Investing Cash Flow
-30,283.0000
-55,200.0000
-93,499.0000
-127,901.0000
-45,274.0000
Financing Cash Flow
-5,244.0000
230,893.0000
63,173.0000
344,964.0000
819,833.0000
End Cash Position
553,424.0000
402,452.0000
495,797.0000
811,464.0000
1,322,593.0000
Capital Expenditure
-30,283.0000
-55,200.0000
-93,222.0000
-127,901.0000
-47,352.0000
Issuance of Capital Stock
-182.0000
236,086.0000
67,394.0000
404,062.0000
867,717.0000
Issuance of Debt
--
--
--
--
49,860.0000
Repayment of Debt
-5,003.0000
-5,193.0000
-4,221.0000
-28,183.0000
-97,744.0000
Repurchase of Capital Stock
--
--
--
-30,915.0000
--
Free Cash Flow
94,525.0000
-323,087.0000
-379,399.0000
-861,029.0000
475,051.0000
12/31/2020 - 8/14/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1MRNA.MI Moderna, Inc.
39.44
-2.13%
IPSC Century Therapeutics, Inc.
0.8207
-3.45%
LYRA Lyra Therapeutics, Inc.
0.1828
-0.16%
NRSN NeuroSense Therapeutics Ltd.
1.1100
+4.72%
AIM AIM ImmunoTech Inc.
0.2019
+0.45%
BPTH Bio-Path Holdings, Inc.
0.8074
-1.04%
BCAB BioAtla, Inc.
0.4700
-0.84%
PBYI Puma Biotechnology, Inc.
2.8900
-4.93%
CTMX CytomX Therapeutics, Inc.
0.8500
-2.86%
PRME Prime Medicine, Inc.
2.8000
-1.06%